NCT06462495View on ClinicalTrials.gov

Head-to-head Comparison of [18F]F-PSMA-N5 With [18F]F-PSMA-1007 PET/CT in PCa Diagnosis, Recurrence, and Metastasis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Prostate CancerPET/CT
Interventions
DRUG

[18F]F-PSMA-N5

Each subject receive a single intravenous injection of \[18F\]F-PSMA-N5, and undergo PET/CT imaging within the specificed time.

DRUG

[18F]F-PSMA-1007

Each subject receive a single intravenous injection of \[18F\]F-PSMA-1007, and undergo PET/CT imaging within the specificed time.

Trial Locations (1)

230000

RECRUITING

The First Affiliated Hospital of China University of Science and Technology（Anhui Provincial Hospital）, Hefei

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV